A Branched-Chain Amino Acid-Related Metabolic Signature Characterizes Obese Adolescents with Non-Alcoholic Fatty Liver Disease
Authors:
- Martina GoffredoMGMartina Goffredo
- Nicola SantoroNSNicola Santoro
- Domenico TricòDTDomenico Tricò
- Cosimo GianniniCGCosimo Giannini
- Ebe D’adamoEDEbe D’adamo
- Hongyu ZhaoHZHongyu Zhao
- Gang PengGPGang Peng
- Xiaoqing YuXYXiaoqing Yu
- Tukiet T. LamTLTukiet T. Lam
- Bridget PierpontBPBridget Pierpont
- Sonia CaprioSCSonia Caprio
- Raimund I. HerzogRHRaimund I. Herzog
Open Access
Abstract
Dysregulation of several metabolite pathways, including branched-chain amino acids (BCAAs), are associated with Non-Alcoholic Fatty Liver Disease (NAFLD) and insulin resistance in adults, while studies in youth reported conflicting results. We explored whether, independently of obesity and insulin resistance, obese adolescents with NAFLD display a metabolomic signature consistent with disturbances in amino acid and lipid metabolism. A total of 180 plasma metabolites were measured by a targeted metabolomic approach in 78 obese adolescents with (n = 30) or without (n = 48) NAFLD assessed by magnetic resonance imaging (MRI). All subjects underwent an oral glucose tolerance test and subsets of patients underwent a two-step hyperinsulinemic-euglycemic clamp and/or a second MRI after a 2.2 ± 0.8-year follow-up. Adolescents with NAFLD had higher plasma levels of valine (p = 0.02), isoleucine (p = 0.03), tryptophan (p = 0.02), and lysine (p = 0.02) after adjustment for confounding factors. Circulating BCAAs were negatively correlated with peripheral and hepatic insulin sensitivity. Furthermore, higher baseline valine levels predicted an increase in hepatic fat content (HFF) at follow-up (p = 0.01). These results indicate that a dysregulation of BCAA metabolism characterizes obese adolescents with NAFLD independently of obesity and insulin resistance and predict an increase in hepatic fat content over time.Keywords
Funding Information
- National Institutes of Health (K08 DK082618, R01 DK101984, R01-HD40787, R01-HD28016, K24-HD01464)
- American Heart Association (13SDG14640038, 11CRP5620013, 16IRG27390002)
- Yale Center for Clinical Investigation, Yale School of Medicine (2012 YCCI Scholar Award, YCCI just in time grant)
- Yale Diabetes Research Center and Clinical and Translational Science Awards (UL1-RR- 024139)
This publication has 53 references indexed in Scilit:
- Elevation of branched-chain amino acid levels in diabetes and NAFL and changes with antidiabetic drug treatmentObesity Research & Clinical Practice, 2015
- Branched chain amino acid metabolism profiles in progressive human nonalcoholic fatty liver diseaseAmino Acids, 2014
- Mapping of the circulating metabolome reveals α-ketoglutarate as a predictor of morbid obesity-associated non-alcoholic fatty liver diseaseInternational Journal of Obesity, 2014
- Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis in Obese Adolescents: A Looming Marker of Cardiac DysfunctionHepatology, 2013
- Circulating Lysophosphatidylcholines Are Markers of a Metabolically Benign Nonalcoholic Fatty LiverDiabetes Care, 2013
- Advances in Pediatric Nonalcoholic Fatty Liver DiseasePediatric Clinics of North America, 2011
- Plasma metabolomic profile in nonalcoholic fatty liver diseaseMetabolism, 2011
- Ethnic differences in lipoprotein subclasses in obese adolescents: importance of liver and intraabdominal fat accretionThe American Journal of Clinical Nutrition, 2010
- Central Role of Fatty Liver in the Pathogenesis of Insulin Resistance in Obese AdolescentsDiabetes Care, 2010
- Influence of Gender, Race, and Ethnicity on Suspected Fatty Liver in Obese AdolescentsPediatrics, 2005